Literature DB >> 22170543

Demographics, socio-behavioral factors, and drug use patterns: what matters in spontaneous HCV clearance?

Dimpy P Shah1, Carolyn Z Grimes, Eric Brown, Lu-Yu Hwang.   

Abstract

Hepatitis C virus (HCV), an emerging bloodborne pathogen, causes chronic liver disease frequently except in about 10-20% of infections which undergo spontaneous resolution. Investigating factors that influence viral clearance is essential to understand the natural history of this infection and establishing novel strategies for prevention and treatment. HCV clearance was estimated in a unique cohort of 1,260 HIV and HBV negative current drug users enrolled for a hepatitis B vaccination study. It was defined as the inability to detect viral RNA using a PCR method in presence of serum anti-HCV antibody EIA. Associated demographic and socio-behavioral factors including drug use patterns were identified from the enrolled subjects using multivariate regression analysis. 33.3% (420/1260) of drug users were found positive for anti-HCV antibodies and 14.8% (62/420) of these individuals achieved viral clearance (negative PCR test). Race or ethnicity of the participants was the only significant factor associated with HCV clearance. Hispanics (OR = 3.4, 95% CI: 1.3-8.5, P = 0.01) and Caucasians (OR = 3.1, 95% CI: 1.5-6.6, P = 0.003) had significantly higher odds of clearing the virus compared to African Americans when adjusted for age and gender. None of the socio-behavioral factors including alcohol intake and drug use patterns were significant determinants of HCV clearance. Racial or ethnic differences in HCV clearance were observed in this study suggesting an important role of host genetic susceptibility factors in determining the clinical course of this disease. Further research is needed to examine these genetic associations of host-virus relationships.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22170543      PMCID: PMC3252024          DOI: 10.1002/jmv.22271

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  26 in total

1.  Lipids, lipases, and obesity: does race matter?

Authors:  P W Wilson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-08       Impact factor: 8.311

2.  The natural history of hepatitis C virus infection: host, viral, and environmental factors.

Authors:  D L Thomas; J Astemborski; R M Rai; F A Anania; M Schaeffer; N Galai; K Nolt; K E Nelson; S A Strathdee; L Johnson; O Laeyendecker; J Boitnott; L E Wilson; D Vlahov
Journal:  JAMA       Date:  2000-07-26       Impact factor: 56.272

3.  Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor.

Authors:  V Agnello; G Abel; M Elfahal; G B Knight; Q X Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

4.  Racial differences in HLA class II associations with hepatitis C virus outcomes.

Authors:  C L Thio; D L Thomas; J J Goedert; D Vlahov; K E Nelson; M W Hilgartner; S J O'Brien; P Karacki; D Marti; J Astemborski; M Carrington
Journal:  J Infect Dis       Date:  2001-05-30       Impact factor: 5.226

5.  Accelerated hepatitis B vaccination schedule among drug users: a randomized controlled trial.

Authors:  Lu-Yu Hwang; Carolyn Z Grimes; Thanh Quoc Tran; April Clark; Rui Xia; Dejian Lai; Catherine Troisi; Mark Williams
Journal:  J Infect Dis       Date:  2010-10-11       Impact factor: 5.226

6.  The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.

Authors:  Gregory L Armstrong; Annemarie Wasley; Edgar P Simard; Geraldine M McQuillan; Wendi L Kuhnert; Miriam J Alter
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

7.  Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research.

Authors:  M Thursz; R Yallop; R Goldin; C Trepo; H C Thomas
Journal:  Lancet       Date:  1999 Dec 18-25       Impact factor: 79.321

8.  HLA-Cw*04 and hepatitis C virus persistence.

Authors:  Chloe L Thio; Xiaojiang Gao; James J Goedert; David Vlahov; Kenrad E Nelson; Margaret W Hilgartner; Stephen J O'Brien; Peter Karacki; Jacquie Astemborski; Mary Carrington; David L Thomas
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

9.  Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection.

Authors:  Kimberly Page; Judith A Hahn; Jennifer Evans; Stephen Shiboski; Paula Lum; Eric Delwart; Leslie Tobler; William Andrews; Lia Avanesyan; Stewart Cooper; Michael P Busch
Journal:  J Infect Dis       Date:  2009-10-15       Impact factor: 5.226

10.  Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.

Authors:  Dongliang Ge; Jacques Fellay; Alexander J Thompson; Jason S Simon; Kevin V Shianna; Thomas J Urban; Erin L Heinzen; Ping Qiu; Arthur H Bertelsen; Andrew J Muir; Mark Sulkowski; John G McHutchison; David B Goldstein
Journal:  Nature       Date:  2009-08-16       Impact factor: 49.962

View more
  6 in total

1.  The effects of alcohol on spontaneous clearance of acute hepatitis C virus infection in females versus males.

Authors:  Judith I Tsui; Ali Mirzazadeh; Judith A Hahn; Lisa Maher; Julie Bruneau; Jason Grebely; Margaret Hellard; Arthur Y Kim; Naglaa H Shoukry; Andrea L Cox; Maria Prins; Gregory J Dore; Georg Lauer; Andrew R Lloyd; Kimberly Page
Journal:  Drug Alcohol Depend       Date:  2016-10-26       Impact factor: 4.492

2.  Differentially regulated gene expression associated with hepatitis C virus clearance.

Authors:  Carolyn Z Grimes; Lu-Yu Hwang; Peng Wei; Dimpy P Shah; Kelly A Volcik; Eric L Brown
Journal:  J Gen Virol       Date:  2012-11-14       Impact factor: 3.891

3.  Baseline HCV Antibody Prevalence and Risk Factors among Drug Users in China's National Methadone Maintenance Treatment Program.

Authors:  Changhe Wang; Cynthia X Shi; Keming Rou; Yan Zhao; Xiaobin Cao; Wei Luo; Enwu Liu; Zunyou Wu
Journal:  PLoS One       Date:  2016-02-23       Impact factor: 3.240

Review 4.  Spontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysis.

Authors:  Daniel J Smith; Ashly E Jordan; Mayu Frank; Holly Hagan
Journal:  BMC Infect Dis       Date:  2016-09-05       Impact factor: 3.090

5.  Prevalence of Hepatitis C among Egyptian Children with Sickle Cell Disease and the Role of IL28b Gene Polymorphisms in Spontaneous Viral Clearance.

Authors:  Somaia Mohammed Mousa; Mona Kamal El-Ghamrawy; Heba Gouda; Mervat Khorshied; Dina Abd El-Salam Ahmed; Hala Shiba
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-01-01       Impact factor: 2.576

6.  The Associations of HLA-A*02:01 and DRB1*11:01 with Hepatitis C Virus Spontaneous Clearance Are Independent of IL28B in the Chinese Population.

Authors:  Jieting Huang; Ke Huang; Ru Xu; Min Wang; Qiao Liao; Huaping Xiong; Chengyao Li; Xi Tang; Zhengang Shan; Ming Zhang; Xia Rong; Kenrad Nelson; Yongshui Fu
Journal:  Sci Rep       Date:  2016-08-11       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.